Adjuvant chemoradiotherapy with carboplatin and a fluoropyrimidine for resectable gastric and gastroesophageal junction cancer: A retrospective review of the Stanford experience

被引：0
|
作者：
de Bruin, M. A.
Kunz, P. L.
Sharma, V. B.
Norton, J. A.
Bastidas, J.
Chang, D. T.
Koong, A. C.
Koong, A. C.
Balise, R. R.
Ford, J. M.
Fisher, G. A.
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Valley Med Oncol Consultants, Fremont, CA USA
[3] El Camino Hosp, Los Gatos, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15674
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PATIENT EXPERIENCE ASSESSMENTS IN ADVANCED GASTRIC, ESOPHAGEAL, AND GASTROESOPHAGEAL JUNCTION CANCER STUDIES
    Morlock, R.
    Turnbull, J.
    Rhode, T.
    Hawiyluk, E.
    Gwaltney, C.
    Paty, J.
    Holmstrom, S.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A452 - A452
  • [32] Perioperative chemotherapy versus adjuvant chemotherapy strategies in resectable gastric and gastroesophageal cancer: A Markov decision analysis
    Choi, Minsig
    Ishizawa, Sayaka
    Kraemer, David
    Sasson, Aaron
    Feinberg, Eugene
    [J]. EJSO, 2022, 48 (02): : 403 - 410
  • [33] Total neoadjuvant chemotherapy with FOLFIRINOX regimen in patients with resectable locally advanced gastric and gastroesophageal junction cancer
    Sedova, M. V.
    Batov, M. A.
    Kolomeytseva, A. A.
    Khomyakov, V. M.
    Volchenko, N. N.
    Fedenko, A. A.
    Kaprin, A. D.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S881 - S881
  • [34] MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
    Janjigian, Yelena Y.
    Van Cutsem, Eric
    Muro, Kei
    Wainberg, Zev
    Al-Batran, Salah-Eddin
    Hyung, Woo Jin
    Molena, Daniela
    Marcovitz, Michelle
    Ruscica, Dario
    Robbins, Scott H.
    Negro, Alejandra
    Tabernero, Josep
    [J]. FUTURE ONCOLOGY, 2022, 18 (20) : 2465 - 2473
  • [35] Capecitabine, oxaliplatin and irinotecan (COI regimen) as perioperative treatment of resectable gastric or gastroesophageal junction (GEJ) cancer
    Berenato, R.
    Pietrantonio, F.
    Niger, M.
    Caporale, M.
    Ricchini, F.
    Maggi, C.
    Bossi, I.
    Consonni, P. V.
    de Braud, F.
    Di Bartolomeo, M.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 94 - 94
  • [36] Adjuvant chemoradiotherapy versus adjuvant chemotherapy for R1 resected gastric cancer: a retrospective cohort study
    Zhou, Meng-Long
    Li, Gui-Chao
    Yang, Wang
    Deng, Wei-Juan
    Hu, Ran
    Wang, Yan
    Long, Zi-Wen
    Liu, Xiao-Wen
    Wang, Ya-Nong
    Zhang, Zhen
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1089):
  • [37] Neoadjuvant epirubicin, oxaliplatin and capecitabine (EOX) in locally advanced resectable gastroesophageal junction and gastric adenocarcinoma: the experience in our institution
    Martinez, J.
    Limon, M.
    Sanchez, I.
    Falcon, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 24 - 24
  • [38] Toxicity and survival outcomes of adjuvant chemoradiation for gastric and gastroesophageal junction cancer patients treated in period 2006-2009: an institutional experience
    Slavik, M.
    Burkon, P.
    Kazda, T.
    Budikova, M.
    Slavikova, M.
    Dvorakova, E.
    Pospisil, P.
    Gombosova, J.
    Navratilova, P.
    Slampa, P.
    [J]. NEOPLASMA, 2014, 61 (06) : 739 - 746
  • [39] Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
    Dikken, Johan L.
    van Sandick, Johanna W.
    Swellengrebel, H. A. Maurits
    Lind, Pehr A.
    Putter, Hein
    Jansen, Edwin P. M.
    Boot, Henk
    van Grieken, Nicole C. T.
    van de Velde, Cornelis J. H.
    Verheij, Marcel
    Cats, Annemieke
    [J]. BMC CANCER, 2011, 11
  • [40] ASO Visual Abstract: Neoadjuvant versus Postoperative Chemoradiotherapy Is Associated with Improved Survival in Patients with Resectable Gastric and Gastroesophageal Cancer
    Kim, Daniel W.
    Lee, Grace
    Hong, Theodore S.
    Li, Guichao
    Horick, Nora K.
    Roeland, Eric
    Keane, Florence K.
    Eyler, Christine
    Drapek, Lorraine C.
    Ryan, David P.
    Allen, Jill N.
    Berger, David
    Parikh, Aparna R.
    Mullen, John T.
    Klempner, Sam
    Clark, Jeffrey W.
    Wo, Jennifer Y.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 690 - 691
12345